PMC:7408073 / 89573-90027 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T496","span":{"begin":211,"end":217},"obj":"Body_part"}],"attributes":[{"id":"A496","pred":"fma_id","subj":"T496","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"Unfortunately, no comparisons of the two ARDS groups with healthy subjects (interquartile range 35–66 pg/mL, markedly lower than both patient groups [179]) were reported; this is important to consider since the plasma concentrations of the RAS peptides may significantly differ depending on method of detection (ELISA versus vs. mass spectrometry) and, in particular, on protocol of determination (endogenous versus equilibrium Ang peptide levels [179])."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T177","span":{"begin":240,"end":243},"obj":"Body_part"}],"attributes":[{"id":"A177","pred":"uberon_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"}],"text":"Unfortunately, no comparisons of the two ARDS groups with healthy subjects (interquartile range 35–66 pg/mL, markedly lower than both patient groups [179]) were reported; this is important to consider since the plasma concentrations of the RAS peptides may significantly differ depending on method of detection (ELISA versus vs. mass spectrometry) and, in particular, on protocol of determination (endogenous versus equilibrium Ang peptide levels [179])."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3280","span":{"begin":134,"end":141},"obj":"Species"},{"id":"3314","span":{"begin":41,"end":45},"obj":"Disease"}],"attributes":[{"id":"A3280","pred":"tao:has_database_id","subj":"3280","obj":"Tax:9606"},{"id":"A3314","pred":"tao:has_database_id","subj":"3314","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Unfortunately, no comparisons of the two ARDS groups with healthy subjects (interquartile range 35–66 pg/mL, markedly lower than both patient groups [179]) were reported; this is important to consider since the plasma concentrations of the RAS peptides may significantly differ depending on method of detection (ELISA versus vs. mass spectrometry) and, in particular, on protocol of determination (endogenous versus equilibrium Ang peptide levels [179])."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T526","span":{"begin":41,"end":45},"obj":"Disease"}],"attributes":[{"id":"A526","pred":"mondo_id","subj":"T526","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"Unfortunately, no comparisons of the two ARDS groups with healthy subjects (interquartile range 35–66 pg/mL, markedly lower than both patient groups [179]) were reported; this is important to consider since the plasma concentrations of the RAS peptides may significantly differ depending on method of detection (ELISA versus vs. mass spectrometry) and, in particular, on protocol of determination (endogenous versus equilibrium Ang peptide levels [179])."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1083","span":{"begin":96,"end":98},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T1084","span":{"begin":102,"end":104},"obj":"http://purl.obolibrary.org/obo/CLO_0008426"},{"id":"T1085","span":{"begin":211,"end":217},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T1086","span":{"begin":244,"end":252},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T1087","span":{"begin":432,"end":439},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"Unfortunately, no comparisons of the two ARDS groups with healthy subjects (interquartile range 35–66 pg/mL, markedly lower than both patient groups [179]) were reported; this is important to consider since the plasma concentrations of the RAS peptides may significantly differ depending on method of detection (ELISA versus vs. mass spectrometry) and, in particular, on protocol of determination (endogenous versus equilibrium Ang peptide levels [179])."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T91178","span":{"begin":240,"end":243},"obj":"Chemical"},{"id":"T58980","span":{"begin":244,"end":252},"obj":"Chemical"},{"id":"T378","span":{"begin":432,"end":439},"obj":"Chemical"}],"attributes":[{"id":"A84035","pred":"chebi_id","subj":"T91178","obj":"http://purl.obolibrary.org/obo/CHEBI_63620"},{"id":"A74571","pred":"chebi_id","subj":"T58980","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A4781","pred":"chebi_id","subj":"T378","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"Unfortunately, no comparisons of the two ARDS groups with healthy subjects (interquartile range 35–66 pg/mL, markedly lower than both patient groups [179]) were reported; this is important to consider since the plasma concentrations of the RAS peptides may significantly differ depending on method of detection (ELISA versus vs. mass spectrometry) and, in particular, on protocol of determination (endogenous versus equilibrium Ang peptide levels [179])."}

{"project":"LitCovid-sentences","denotations":[{"id":"T436","span":{"begin":0,"end":454},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Unfortunately, no comparisons of the two ARDS groups with healthy subjects (interquartile range 35–66 pg/mL, markedly lower than both patient groups [179]) were reported; this is important to consider since the plasma concentrations of the RAS peptides may significantly differ depending on method of detection (ELISA versus vs. mass spectrometry) and, in particular, on protocol of determination (endogenous versus equilibrium Ang peptide levels [179])."}

{"project":"2_test","denotations":[{"id":"32708755-25107336-20678988","span":{"begin":150,"end":153},"obj":"25107336"},{"id":"32708755-25107336-20678989","span":{"begin":448,"end":451},"obj":"25107336"}],"text":"Unfortunately, no comparisons of the two ARDS groups with healthy subjects (interquartile range 35–66 pg/mL, markedly lower than both patient groups [179]) were reported; this is important to consider since the plasma concentrations of the RAS peptides may significantly differ depending on method of detection (ELISA versus vs. mass spectrometry) and, in particular, on protocol of determination (endogenous versus equilibrium Ang peptide levels [179])."}